Legal & General Group PLC Evelo Biosciences, Inc. Transaction History

Legal & General Group PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$1.46 - $3.55 $4,765 - $11,587	-3,264 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.07 - $12.0 $309 - $612	51 Added 1.59%	3,264 $20,000
Q2 2021 Aug 12, 2021	BUY	$9.43 - $16.6 $6,553 - $11,537	695 Added 27.6%	3,213 $44,000
Q1 2021 May 17, 2021	BUY	$9.71 - $18.6 $2,466 - $4,724	254 Added 11.22%	2,518 $27,000
Q4 2020 Feb 12, 2021	SELL	$3.91 - $12.28 $1,614 - $5,071	-413 Reduced 15.43%	2,264 $27,000
Q3 2020 Nov 13, 2020	BUY	$3.81 - $5.73 $2,849 - $4,286	748 Added 38.78%	2,677 $14,000
Q2 2020 Aug 14, 2020	BUY	$3.53 - $6.12 $1,436 - $2,490	407 Added 26.74%	1,929 $9,000
Q1 2020 May 14, 2020	SELL	$3.21 - $7.06 $2,311 - $5,083	-720 Reduced 32.11%	1,522 $6,000
Q4 2019 Feb 13, 2020	BUY	$3.81 - $7.45 $381 - $745	100 Added 4.67%	2,242 $9,000
Q4 2018 Feb 15, 2019	BUY	$7.29 - $13.01 $9,826 - $17,537	1,348 Added 169.77%	2,142 $28,000
Q2 2018 Aug 10, 2018	BUY	$11.39 - $16.26 $9,043 - $12,910	794 New	794 $9,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.